SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue109,333128,367146,444162,556
Cost of Revenue26,75647,21835,84327,689
Gross Profit82,57781,149110,601134,867
Operating Expenses
Research Development94,95665,89559,12351,073
Selling General and Administrative90,70077,16786,01888,064
Non Recurring----
Others----
Total Operating Expenses240,510217,927206,930197,985
Operating Income or Loss-131,177-89,560-60,486-35,429
Income from Continuing Operations
Total Other Income/Expenses Net11,167-18,466-11,597-16,807
Earnings Before Interest and Taxes-131,177-89,560-60,486-35,429
Interest Expense-3,132-8,072-9,694-9,212
Income Before Tax-120,010-108,026-72,083-52,236
Income Tax Expense1-16,778-2,313406
Minority Interest----
Net Income From Continuing Ops-120,011-91,248-69,770-52,642
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-120,011-91,248-69,770-52,642
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-120,011-91,248-69,770-52,642